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Abstract
Hepatitis E virus (HEV) is a growing public health problem in many countries. In this study,
we investigated HEV seroprevalence among the general population in the Siem Reap prov-
ince, Cambodia, and performed HEV genetic analysis with the aim to develop an HEV pre-
vention strategy. This seroepidemiological cross-sectional study conducted from 2010 to
2014 included 868 participants from four different locations in Siem Reap province, Cambo-
dia. They answered questionnaires and provided blood samples for the analysis of hepatitis
virus infections. Among the participants (360 men and 508 women; age range, 7–90 years),
the prevalence of anti-HEV IgG was 18.4% (95% confidence interval: 15.9–21.0); HEV
RNA was detected in two participants (0.23%) and was classified as genotype 3 and 4. Full-
length genome of the genotype 4 isolate, CVS-Sie10, was sequenced; it contained 7,222
nucleotides and three ORFs and demonstrated high sequence identity with the swine China
isolates swGX40 (95.57%), SS19 (94.37%), and swDQ (91.94%). Multivariate logistic
regression analysis revealed that men, elderly people, and house workers were risk groups
significantly associated with the positivity for anti-HEV IgG. This is the first report on the
detection of HEV genotype 4 in humans in Cambodia and on the complete genome
sequence of HEV genotype 4 from this country. Our study demonstrates that new HEV
infection cases occur frequently among the general population in Cambodia, and effective
preventive measures are required.
Introduction
World Health Organization (WHO) statistics indicates that approximately 20 million people
are hepatitis E virus (HEV)-infected, over 3 million have acute hepatitis E, and 70,000 die of
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hepatitis E every year worldwide [1, 2]. HEV is transmitted mainly through the fecal-oral route
because of fecal contamination of drinking water; therefore, low sanitation standards increase
the risk of HEV infection [1] which is a common cause of hepatitis outbreaks in the developing
world [2]. In Cambodia, one of the developing countries in Asia, HEV infection can be an
important health problem.
According to genome sequence, HEV has been classified into four genotypes; recently, new
HEV genotype 5 has been identified in a wild boar in Japan [3]. HEV genotypes differ in their
epidemiology and severity of infection. Genotype 1 is usually detected during hepatitis E out-
breaks in developing countries in Asia, Africa, and South America; genotype 2 has been identi-
fied in Mexico, Chad, and Nigeria, while genotype 3 is more common in the developed
countries, and genotype 4 has been found mainly in Asia, including Japan, China, and Taiwan
[1, 4]. HEV genotype is one of the important risk factors associated with the disease severity
[5–7]. In Cambodia, HEV RNA of genotype 3 has been detected in river water [8] and swine
[9]; HEV genotype 1 has also been identified in swine [9]; in patients, anti-HEV IgG and IgM
have been found [10, 11]. However, the full-length genome sequence of HEV isolated in Cam-
bodia has not yet been submitted in the DDBJ/EMBL/GenBank database. We have been con-
ducting a seroepidemiological survey on hepatitis virus infections among the general
population in Cambodia since 2010 and have reported the seroprevalence and genotype distri-
bution of hepatitis B and C virus among adults in this country [12]. In the current study con-
ducted in collaboration with the Ministry of Health in Cambodia, we investigated the
prevalence of HEV infection among the general population in Siem Reap province and
sequenced full-length genome of the HEV isolate recovered from an HEV RNA-positive
individual.
Materials and Methods
Study design
We conducted a cross-sectional study among the general population in Siem Reap province,
Cambodia. Based on anticipated anti-HEV IgG rate of 15%, relative precision of 15%, confi-
dence coefficient of 95% and the population size of approximately 3,000 (information from the
village/commune chiefs), sample size was calculated to be 755. Therefore, intended sample size
was determined to be 800.
Participants
Seroepidemiological surveys were performed eight times: in February and August, 2010; Febru-
ary and July, 2011; February and August, 2012; June, 2013; and June, 2014 among the general
population of Chrey village, Sasar Sdam commune, Krabei Riel commune, and Rohal village in
Siem Reap, a province in northwestern Cambodia. The proportion of main activity of general
population in Cambodia was 51.8% of employed, 24.7% of student from the data of general
population census of Cambodia 2008[13]. Then, we selected Sasar Sdam commune including
elementary school according to the characteristic of the population, and three locations which
have different background; Chrey was a new urban village, Krabei Riel was an old commune,
and Rohal was a sightseeing craft village. On the day of the survey, a duty officer of the Ministry
of Health, Cambodia, explained the study protocol to the participants or parents of elementary
school students before they were enrolled in the study. The participants who were the residents
of Chrey village (333 of total 2034; 16.4%), Krabei Riel commune (189 of total 447; 42.3%), and
Rohal village (49 of total 100; 49.0%) were enrolled in this study by the village/commune chiefs.
In Sasar Sdam commune, the participants included 240 of total 282 (85.1%) third-year elemen-
tary school students (as of 2011) and 57 people living around the school.
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Ethical permission
This study, which was based on questionnaires and blood sample analyses for hepatitis virus
infections, was approved by the Ethics Committees for epidemiological research of Hiroshima
University, Japan, and the Ministry of Health, Cambodia. Written informed consent was
obtained from all the participants or parents of elementary school students. We informed the
participants about the results of serological tests for hepatitis virus infections and provided the
pamphlet with healthcare information approximately six months later.
Questionnaires
Questionnaires were used to determine participants’ characteristics such as age, sex, occupa-
tion, current health status, current periodic treatment, history of disease or a major injury, his-
tory of injection or infusion, operation, blood transfusion, tattoo and holes for pierced
earrings.
Serological tests
About 10 ml of blood drawn from each participant was carefully centrifuged, and the serum
samples were transported to Hiroshima University in Japan, where they were tested for hepati-
tis virus markers to determine the prevalence of hepatitis virus infection. HEV infection was
identified by the presence of anti-HEV IgG and IgM antibodies detected using the enzyme
immunoassay(EIA) with IgG/IgM anti-HEV EIA (Institute of Immunology Co., Ltd, Tokyo,
Japan), and anti-HEV IgA was detected using IMMUNIS IgA anti-HEV EIA (Institute of
Immunology). Hepatitis B virus (HBV) was identified based on seropositivity for hepatitis B
surface antigen (HBsAg) detected by the reversed passive hemagglutination assay with Mycell
II HBsAg (Institute of Immunology), hepatitis B surface antibody (anti-HBs) detected by pas-
sive hemagglutination (PHA) using Mycell II anti-HBs (Institute of Immunology) or Chemilu-
minescence Immunoassay (CLIA) using Architect Osabu (Abbott, Tokyo, Japan), or hepatitis
B core antibody (anti-HBc) detected by PHA using Mycell anti-rHBc (Institute of Immunol-
ogy) or CLIA with Architect HBc II (Abbott, Tokyo, Japan); a sample was considered HBV
infection if either HBsAg or anti-HBc were detected with or without anti-HBs. Hepatitis C
virus (HCV) infection was confirmed by seropositivity for anti-HCV antibodies by the particle
agglutination test using Ortho HCV Ab PA test II (Ortho-Clinical Diagnostics, Inc., Tokyo,
Japan). Hepatitis A virus (HAV) infection was detected by CLIA with Architect HAVAB- G
(Abbott). HIV infection was determined by the gelatin-particle agglutination test with Serodia
HIV-1/2 (Fujirebio Inc., Tokyo, Japan) and the presence of HIV RNA detected by reverse tran-
scription (RT)-PCR [14].
Detection of HEV RNA
Nucleic acids were extracted from serum samples using Smitest EX-R & D (Medical & Biologi-
cal Laboratories Co., Ltd. Nagano, Japan). HEV RNA was determined in each anti-HEV IgG-
positive sample and in pooled sera of every 10 anti-HEV IgG-negative samples by nested
RT-PCR with HE5 primers targeting ORF1 of the HEV genome [15].
HEV full-length genome sequencing
HEV genomic RNA was reverse transcribed and cDNA was amplified by PCR using primers
specific for 12 overlapping regions in the HEV genome (Table 1). Reverse transcription and
first-round PCR were conducted using the PrimeScript II High Fidelity One Step RT-PCR Kit
(Takara Bio, Inc., Shiga, Japan); second-round PCR was conducted using PrimeSTAR GXL
Hepatitis E Virus in Cambodia
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Table 1. Hepatitis E Virus-specific oligonucleotide primers used in this study.
Primers Stage-polarity Nucleotide sequence (5'-3')
Primer set A 1st sense GCAGACCACGTATGTGGTCG
2nd sense CCACGTATGTGGTCGACGCC
1st antisense ATRGACACATCATGRTTRTA
2nd antisense CCGGCACTRGARTCNCCCTC
Primer set B 1st sense GCGGARGCNATGGCYCGYCA
2nd sense GGCATGACYCGGYTSTAYGC
1st antisense TARTCACGSCCRGAYTTYTC
2nd antisense CARCTRTARAGGCGYGTTAT
Primer set C 1st sense AAGTCNACATTTCAYGCCGT
2nd sense GTGCAYATATGGGAYAGGCT
1st antisense CCTCCRATRAGRGARTGCCG
2nd antisense TGRACRCAGCGRTTRAACCT
Primer set D 1st sense AYTWTGGGYAATAARACYTT
2nd sense CCCAGYTRGAGGYCAAYGG
1st antisense TTRGAYGCATTRACCAGCCA
2nd antisense CCRTCAGGRTARGTRTGRAG
Primer set E 1st sense CTAAYCCYTTYTGYGGKGA
2nd sense CTYTAYACYCGSACYTGGTC
1st antisense AGYGANGGGGCCTCRTCRAT
2nd antisense GGTGTRTARGCTGCRAACCC
Primer set F 1st sense AGYTTYGATGCYTGGGARCG
2nd sense CCAGCYATAGCYTGGTTYGA
1st antisense ATRCCNACCTCRCGRAGRAG
2nd antisense GCATCRACMACCACRCAYTT
Primer set G 1st sense GTYCATGARGCYCARGGYGC
2nd sense TTYACTGAGACYACRATTAT
1st antisense TTYTCAATAGCRCGRAACCA
2nd antisense GTYTTRCTCCAYGCRGATAT
Primer set H 1st sense AAYGTYACYACCTGYGAGCT
2nd sense GAGCTYGTRGAGGCYATGGT
1st antisense TGCGAAACAACATCMACACA
2nd antisense GCCACATTMGTTARCTTTCGCA
Primer set I 1st sense AAYACYGTYTGGAAYATGGC
2nd sense GGGGATGAYTCTGTTGTRCT
1st antisense CGGCGAAGCCCCAGCTGGGG
2nd antisense AGCGGCGGGGCGCTGGGAYTG
Primer set J 1st sense GTGGTTTCTGGGGTGACCGG
2nd sense TTCTCAGCCCTTCGCCCTCC
1st antisense TTAGTRTARGARTTYACAGG
2nd antisense CCATGRATRCARAGCATRAC
Primer set K 1st sense TCYATYTCYTTYTGGCCYCA
2nd sense CCRACGTCYGTNGAYATGAA
1st antisense ACAGTRTCAGARACATACAT
2nd antisense AGCCARAGYACRTCATTRGC
Primer set L 1st sense GTCTCAGCCAATGGCGAGC
2nd sense GTYGAGAAYGCYCAGCAGGA
1st antisense CARAATAAATCAATACTCCCG
2nd antisense TACCCACCTTCATYTTRAGACG
doi:10.1371/journal.pone.0136903.t001
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DNA Polymerase (Takara Bio, Inc.). The 30-Full RACE Core Set (Takara Bio, Inc.) was used to
amplify core 30 sequences. Final products were sequenced using a 3730xl DNA sequencer and
the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA,
USA).
Molecular evolutionary analyses
The number of nucleotide substitutions per site was estimated by a six-parameter modeling
method [16], and phylogenetic trees were constructed by the neighbor-joining method [17]
based on the number of substitutions. To confirm the credibility of phylogenetic analyses,
bootstrap resampling tests were carried out 1,000 times [18]. The analyses were performed
using the GENETYX-MAC version 17 software (Genetyx Corporation, Tokyo, Japan).
Statistical analysis
The data were analyzed using the JMP 10 software (SAS Institute Inc., Cary, NC, USA). Pro-
portions were estimated with the 95% confidence interval (CI); χ2 test or Fisher’s exact test and
Mantel-extension test for trend were performed to evaluate the difference in the prevalence of
viral markers among sex, age, residential, and occupational groups. Univariate analysis using
χ2 test or Fisher’s exact test and multivariate logistic regression analysis were performed to
identify potential risk factors for HEV infection by calculating odds ratios (ORs) and 95% CI.
The explanatory variables were sex (reference: woman), age group (reference: 7–19 years old),
location (reference: Chrey village), occupation (reference: farmer), and HBV or HCV infection
(reference: positive). For all analyses, a p-value< 0.05 was considered statistically significant.
Results
Characteristics of the participants
Participants’ characteristics are shown in Table 2. In total, there were 868 people, 360 men
(41.5%) and 508 women (58.5%); age distribution was from 7 to 90 years (mean, 30.5 ± 18.8;
median, 29 years) as of 2014. Among the participants, 38.4% lived in Chrey village, 34.2% in
Sasar Sdam commune, 21.8% in Krabei Riel commune, and 5.6% in Rohal village, Siem Reap
Province. In terms of occupation, most of the participants were students (40.1%), followed by
farmers (33.2%), house workers (7.5%), office workers (6.9%), and craftsmen (2.4%). Other
results of the questionnaire are shown in S1 Table.
HEV infection prevalence
The results of serologic testing are shown in Table 3. Overall, the prevalence of anti-HEV IgG
was 18.4% (160/868; [95% CI: 15.9–21.0%]). Anti-HEV IgG positivity was significantly higher
in men than in women (21.9% vs. 15.9%; p = 0.0247) and showed statistically significant corre-
lation with older age (p< 0.0001). Anti-HEV IgG prevalence differed significantly among the
four analyzed locations (p< 0.0001). There was also significant difference among occupa-
tional/professional groups (p< 0.0001) (Table 3).
HEV RNA was detected in two participants (0.23% [0–0.55%]) (Table 3). There were no sig-
nificant differences in the positivity rate of HEV RNA among sex, age, residential, and occupa-
tional groups. Full-length HEV genome could be sequenced for one of the two samples and
was classified as genotype 4. Another HEV RNA positive isolate was classified as genotype 3
based on partial ORF1 sequence with HE5 primers [15].
The two HEV RNA-positive participants were analyzed for other hepatitis viruses and HIV
(Table 4). They were found positive for anti-HEV IgG and IgM, and one of them was positive
Hepatitis E Virus in Cambodia
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for anti-HEV IgA, as well as anti-HBs and anti-HBc, indicating previous HBV infection. More-
over, one of them was positive for anti-HIV antibody, but HIV RNA was not detected.
Full-length sequence of the HEV genome
The full-length genome sequence of HEV isolate was recovered from a 39-year-old man at the
time of the survey. The isolate designated as CVS-Sie10 (DDBJ/EMBL/GenBank accession
number LC042232) had the genome of 7,222 nucleotides (nt) containing three ORFs: ORF1
[1–5,115 nt; 1,705 amino acids (aa)], ORF2 (5,115–7,136 nt; 674 aa), and ORF3 (5,143–5,484
nt; 114 aa), a 30 UTR, and a poly-A tail.
The alignment of the CVS-Sie10 genome with published HEV genotype 4 sequences showed
that this isolate was close to the swine China isolates swGX40, SS19, and swDQ with sequence
identities of 95.57%, 94.37%, and 91.94%, respectively (Table 5), and the same length of ORF1,
ORF2, and ORF3. CVS-Sie10 displayed weak homology with other HEV genotypes. Thus, it
demonstrated 76.99%, 76.83%, 78.09%, and 79.34% identity with the Burma isolate of genotype
1, the Mexico isolate of genotype 2, the HEV-US2 isolate of genotype 3, and the JBOAR135--
Shiz09 isolate of genotype 5, respectively.
Based on full-length genome sequences of the CVS-Sie10 and other HEV isolates, we con-
structed a phylogenetic tree (Fig 1), which showed that CVS-Sie10 clustered on a branch separate
from the other genotype 4 sequences, and close to the China isolates swGX40, SS19, and swDQ.
Potential risk factors for HEV infection
The odds ratios and p-values of potential risk factors for anti-HEV IgG positivity in univariate
analysis and multivariate logistic regression model are shown in Table 6. In multivariate analysis,
men (AOR: 1.9 [1.2–2.8] p = 0.0025) and older age (if the 7–19-year-old population group is
taken as baseline) were significantly associated with anti-HEV IgG seropositivity. There were no
significant differences among the four locations. The odds ratio of anti-HEV IgG seropositivity
Table 2. Characteristics of participants.
Characteristics Total Men Women
N (%) N (%) N (%)
Age group(yr) 7–19 330 (38.0) 146 (40.6) 184 (36.2)
20–29 118 (13.6) 56 (15.6) 62 (12.2)
30–39 136 (15.7) 48 (13.3) 88 (17.3)
40–49 124 (14.3) 61 (16.9) 63 (12.4)
50–59 85 (9.8) 31 (8.6) 54 (10.6)
60–90 75 (8.6) 18 (5.0) 57 (11.2)
Location Chrey village 333 (38.4) 122 (33.9) 211 (41.5)
Sasar Sdam commune 297 (34.2) 126 (35.0) 171 (33.7)
Krabei Riel commune 189 (21.8) 70 (19.4) 119 (23.4)
Rohal village 49 (5.6) 42 (11.7) 7 (1.4)
Occupation student 348 (40.1) 152 (42.2) 196 (38.6)
farmer 288 (33.2) 118 (32.8) 170 (33.5)
house worker 65 (7.5) 1 (0.3) 64 (12.6)
ofﬁce worker 60 (6.9) 25 (6.9) 35 (6.9)
craftsman 21 (2.4) 10 (2.8) 11 (2.2)
others 86 (9.9) 54 (15.0) 32 (6.3)
Total 868 (100.0) 360 (41.5) 508 (58.5)
doi:10.1371/journal.pone.0136903.t002
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for house workers was more than twice higher than that for farmers (AOR: 2.3 [1.2–4.5];
p = 0.0109), and that for others was significantly higher than farmers (AOR: 1.8 [1.0–3.2];
p = 0.0464). On the other hand, HBV and HCV infections were not associated with anti-HEV
IgG seropositivity.
Discussion
In this study, we performed a seroepidemiological survey for HEV infection in Cambodia. As
a result, we identified the first human case of HEV genotype 4 in Cambodia and performed
Table 3. Sex-, age-, location- and occupation-specific prevalence of anti-HEV IgG and HEV RNA among the general population in Cambodia.
anti-HEV IgG positive HEV RNA positive
N (%) [95% CI] p-Value N (%) [95% CI] p-Value
Total 868 160 (18.4) [15.9–21.0] 2 (0.23) [0–0.55]
Sex Man 360 79 (21.9) [17.7–26.2] 0.0247*a 1 (0.28) [0–0.82] 0.8065a
Woman 508 81 (15.9) [12.8–19.1] 1 (0.20) [0–0.58]
Age group 7–19 330 19 (5.8) [3.2–8.3] <0.0001*c 0 (0.0) [0–1.1] 0.3839b
20–29 118 25 (21.2) [13.8–28.6] 0 (0.0) [0–3.1]
30–39 136 32 (23.5) [16.4–30.7] 1 (0.74) [0–2.2]
40–49 124 36 (29.0) [21.0–37.0] 1 (0.81) [0–2.4]
50–59 85 30 (35.3) [25.1–45.5] 0 (0.0) [0–4.3]
60–90 75 18 (24.0) [14.3–33.7] 0 (0.0) [0–4.9]
Location CV 333 74 (22.2) [17.8–26.7] <0.0001*a 1 (0.30) [0–0.89] 1.0000b
SC 297 29 (9.8) [6.4–13.1] 1 (0.34) [0–1.0]
KC 189 47 (24.9) [18.7–31.0] 0 (0.0) [0–2.0]
RV 49 10 (20.4) [9.1–31.7] 0 (0.0) [0–7.5]
Occupation farmer 288 62 (21.5) [16.8–26.3] <0.0001*a 0 (0.0) [0–1.3] 0.0712b
student 348 24 (6.9) [4.2–9.6] 0 (0.0) [0–1.1]
house worker 65 21 (32.3) [20.9–43.7] 1 (1.5) [0–4.5]
ofﬁce worker 60 18 (30.0) [18.4–41.6] 0 (0.0) [0–6.1]
craftsman 21 7 (33.3) [13.2–53.5] 0 (0.0) [0–17.6]
others 86 28 (32.6) [22.7–42.5] 1 (1.2) [0–3.4]
CV: Chrey village, SC: Sasar Sdam commune, KC: Krabei Riel commune, RV: Rohal village, CI: Conﬁdence Interval
* statistically signiﬁcant variables.
a χ2 test
b Fisher’s exact test
c Mantel-extension test for trend
doi:10.1371/journal.pone.0136903.t003
Table 4. HEV RNA positives among the general population in Cambodia.
No Sex Agea year anti-
HEV
IgG
anti-
HEV
IgM
anti-
HEV
IgA
HEV　
RNA
HEV
genotype
HBsAg anti-
HBs
anti-
HBc
HBV
DNA
anti-
HCV
HCV
RNA
anti-
HAV
anti-
HIV
HIV
RNA
COI COI COI
1 M 39 2010 + 23.4 + 1.2 - 0.7 + 4 - + + - - - + + -
2 F 33 2011 + 6.8 + 2.3 + 3.3 + 3 - + + - - - + - NT
M: Male, F: Female, NT: Not tested, COI: Cut off index
a at survey
doi:10.1371/journal.pone.0136903.t004
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full-length genome sequencing of the isolate. One case of HEV genotype 3 was also detected. In
developing countries, HEV infection is usually caused by genotype 1 viruses [1]; however, the
data obtained in our study shows different genotype. In previous studies in Cambodia, HEV
genotype 3 was detected in river water [8], and genotypes 1 and 3 were recovered from swine
[9]. Partial sequences of HEV genotype 1 (accession number: DQ145797) and genotype 3
(accession number: DQ145792) from humans have been determined, but genotype 4 has not
been reported. In this study, we sequenced, for the first time, the full-length genome of human
HEV genotype 4 isolated in Cambodia.
Two HEV RNA-carrying participants were also positive for anti-HEV IgM and had a prior
history of HBV infection as evidenced by the presence of anti-HBs and anti-HBc antibodies;
one of the participants was also anti-HIV-positive. The detection of anti-HEV IgM indicates
that both individuals had early stages of HEV infection. HEV genotype 4 has been reported to
cause higher rate of aggravation from viral infection than genotype 3 [5, 6, 19], however,
according to their answers to our questionnaire, both participants (genotype 3 and genotype 4)
did not receive periodic treatment in hospitals and did not have serious problems with health.
Moreover, they were confirmed asymptomatic during the interview 6 months after a blood
test. Both of them had a prior history of HBV infection, which is not a rare case for Cambodia,
where adult population has high anti-HBc positive rate of 38.5% [12]. Our multivariate analysis
revealed no association between HEV and HBV infections.
Aggravation due to HEV infection is infrequent, and was not observed in this study. HEV
genotype 4 is more likely to cause aggravation, and sometimes cause death [20, 21]; in recent
years, the risk of HEV triggering chronic hepatitis in immunocompromised patients, including
HIV carriers [22] and organ transplant recipients [23, 24] has been reported. These data under-
score the importance of investigating the prevalence and performing genetic analysis of HEV
infection in Cambodia, which is the part of Asia believed to be heavily affected by HEV infec-
tion, and the necessity of developing preventive measures against HEV spread.
Table 5. Identity of full-genome sequences of HEV isolates known.
Genotype Isolate name Accession
number
Source Nucleotides
length
Identity with
CVS-Sie10 (%)
Amino acids length
Country host ORF1 ORF2 ORF3
4 CVS-Sie10 LC042232 Cambodia (Siem
Reap)
human 7222 1705 674 114
swGX40 EU676172 China (Guangxi) swine 7269 95.57 1705 674 114
SS19 JX855794 China
(Guangdong)
swine 7233 94.37 1705 674 114
swDQ DQ279091 China swine 7234 91.94 1705 674 114
JYK-Tok03C AB291964 Japan (Tokyo) human 7244 87.44 1705 674 114
HEVN2 AB253420 Japan (Okinawa) human 7253 87.40 1707 674 114
EChZ20 HM439284 China (eastern
China)
human 7229 86.59 1704 674 114
W2-5 JQ655736 China (Beijing) human 7261 85.50 1706 674 114
JYI-ChiSai01C AB197674 China (Shanghai) human 7260 85.00 1706 674 114
1 Burma M73218 Burma human 7207 76.99 1693 660 123
2 Mexico M74506 Mexico human 7180 76.83 1691 659 123
3 HEV-US2 AF060669 the United States human 7277 78.09 1708 660 122
5 JBOAR135-Shiz09 AB573435 Japan (Shizuoka) wild
boar
7267 79.34 1708 674 112
doi:10.1371/journal.pone.0136903.t005
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In our survey, the overall rate of anti-HEV IgG positivity among 868 participants was
18.4%. There has been no prior study on the prevalence of HEV infection in the general popu-
lation in Cambodia; however, the rate of anti-HEV IgG positivity in patients with high aspar-
tate transaminase and alanine transaminase levels was determined as 5.5% [10], and the rate
of anti-HEV IgM positivity in feverish patients was 11.1% [11]. Other studies have indicated
that the rate of anti-HEV IgG positivity among blood donors in Japan was 3.4% [25] and in
the general population of the Mekong River basin in Vietnam it was 9% [26]; among the gen-
eral population of the East China Sea coast in the same country it was 28.1% (143/509 [95%
CI: 24.2–32.0%]) (our unpublished data). In China, Taiwan, India, and Thailand, HEV IgG
Fig 1. Phylogenetic tree constructed based on HEV full-length genomes using the neighbor-joining
method. Each of HEV genotypes 1, 2, 3, and 5 is represented by a single isolate, while for genotype 4, all the
isolates with reported complete or near-complete genome sequence are presented. GenBank accession
numbers are shown in parentheses; scale bar indicates nucleotide substitutions per site.
doi:10.1371/journal.pone.0136903.g001
Table 6. Univariate andmultivariate analysis of positivity for anti-HEV IgG among the general population in Cambodia.
anti-HEV IgG
Univariate analysisa Multivariate analysisb
N OR [95% CI] p-Value AOR [95% CI] p-Value
Sex Man 360 1.5 [1.1–2.1] 0.0247* 1.9 [1.2–2.8] 0.0025*
Woman 508 1 1
Age group(yr) 7–19 330 1 1
20–29 118 4.4 [2.3–8.3] <0.0001* 5.7 [1.7–17.8] 0.0037*
30–39 136 5.0 [2.7–9.3] <0.0001* 7.1 [1.8–26.2] 0.0038*
40–49 124 6.7 [3.7–12.3] <0.0001* 9.2 [2.4–34.1] 0.0010*
50–59 85 8.9 [4.7–17.0] <0.0001* 12.3 [3.1–46.3] 0.0002*
60–90 75 5.2 [2.6–10.4] <0.0001* 6.7 [1.6–26.3] 0.0068*
Location CV 333 1 1
SC 297 0.38 [0.24–0.60] <0.0001* 0.95 [0.51–1.8] 0.8708
KC 189 1.2 [0.76–1.8] 0.4912 1.2 [0.71–1.9] 0.5667
RV 49 0.90 [0.43–1.9] 0.7747 0.56 [0.23–1.2] 0.1716
Occupation farmer 288 1 1
student 348 0.27 [0.16–0.45] <0.0001* 1.9 [0.58–5.8] 0.2643
house worker 65 1.7 [0.96–3.1] 0.0642 2.3 [1.2–4.5] 0.0109*
ofﬁce worker 60 1.6 [0.84–2.9] 0.1559 1.5 [0.75–3.1] 0.2231
craftsman 21 1.8 [0.71–4.7] 0.2098 2.5 [0.87–6.8] 0.0742
others 86 1.8 [1.0–3.0] 0.0357* 1.8 [1.0–3.2] 0.0464*
HBV infection positive 247 2.0 [1.4–2.9] <0.0001* 1.1 [0.75–1.7] 0.5593
negative 621 1 1
HCV infection positive 34 1.9 [0.89–4.1] 0.0921 1.2 [0.52–2.7] 0.6224
negative 834 1 1
OR: Odds Ratio, AOR: Adjusted Odds Ratio, CI: Conﬁdence Interval, CV:Chrey village, SC: Sasar Sdam commune, KC: Krabei Riel commune, RV: Rohal
village
a χ2 test or Fisher’s exact test
b Logistic regression analysis: R2 = 0.1113, Model p<0.0001*, N = 868
* statistically signiﬁcant variables
doi:10.1371/journal.pone.0136903.t006
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positivity rate was 20.2%, 10.7%,4.0%, and 2.8–7%, respectively, while in urban and rural
Malaysia, it was 2% and 44–50%, respectively [27]. Compared to these data, the rate of anti-
HEV IgG positivity detected in this study is slightly higher than average. There might be possi-
ble selection bias because we could not perform the random sampling. However, the screening
for hepatitis virus infections does not conducted among the general population in Cambodia.
On the other hand, the sensitivity of detection of anti-HEV IgG differs according to the assay.
We detected by the kit used the purified recombinant HEV ORF2 protein in EIA same as the
method described previously [28]. The results of the detection of anti-HEV IgG using this
recombinant HEV ORF2 protein showed that the positivity of anti-HEV IgG was as high as
98% among the totally 57 acute hepatitis samples with positive for HEV RNA (56/57 samples:
anti-HEV IgM/IgG +/+, HEV RNA +) [28–30](unpublished data). Furthermore, the sensitivity
of the assay was not depend on genotype, and it also showed the high positivity among the
swine [31]. Therefore, we considered that the sensitivity of detection of anti-HEV IgG by our
used assay was high.
Our present results demonstrate that men have a significantly higher rate of HEV infection
than women; similar association has been observed in Japan among blood donors [25], and
reported by the National Epidemiological Surveillance of Infectious Diseases [32]. Moreover,
similar correlation has been shown in the United Kingdom [33, 34], the United States [35], and
China [36]. The reason for such an association is not clear; given that HEV infection is primar-
ily transmitted via the oral route, it can be hypothesized that game meat consumption and
other food preferences may be involved.
Higher prevalence of anti-HEV IgG in older age groups indicates age-related risk. Even
after the adjustment for other factors, older people demonstrate significantly higher rates of
anti-HEV IgG positivity, if the 7–19-year-old population group is taken as baseline. In Vietnam
[26] and Indonesia [37], it has been reported that the rate of anti-HEV positivity rises with age.
Conceivable reason for the correlation of anti-HEV IgG positivity with age is because currently
occurring new infections cause the number of people with a prior history of HEV infection to
increase with age. Although the period when HEV RNA is detectable in the blood after HEV
infection is brief constituting 28.3 days [38], two HEV RNA-positive participants (0.23%: 2/
868 [95%CI: 0–0.55%]) were identified in our cross-sectional study of 868 people. Assuming
that HEV RNA detection period is about four weeks, HEV incidence is estimated at 3.00/100
person-years (0–7.2/100 person-years). Among rural Chinese population, the rate of anti-HEV
IgG positivity was 38%, with the incidence of 2.8/10,000 person-years [36], and in rural Bangla-
desh regarded as HEV endemic region, the prevalence of anti-HEV total Ig was 22.5% and the
incidence was 63.9/1,000 person-years [39]. Compared to these data, HEV incidence deter-
mined in our study can be regarded as high, indicating that infection control measures are
required.
HEV infection is often foodborne in developed countries, including Japan and Europe [4,
6]; in developing countries, contaminated water is considered to be a major cause [40–42].
Thus, there has been an outbreak of HEV infection in southwestern Vietnam along the Hau
river, adjacent to Cambodia [43], and HEV has been detected in the water of Siem Reap River,
Cambodia [8], indicating a possibility that HEV outbreak could also occur in Cambodia. In
turn, HAV positive rate among the participants in this study was 88.8% (767/864; [86.7–
90.9%]): adults (18 years or older) had 99.6% (552/554; [99.1–100.0%]) and minors (17 years
or younger) had 69.4% (215/310; [64.2–74.5%]), indicating age-related effect.
In Cambodia, nearly everyone is assumed to have HAV exposure by the time they reach
adulthood. As with HEV infection, HAV is transmitted via the fecal-oral route, and by adult-
hood, nearly everyone is HAV-infected via contaminated food or water, indicating serious
issues with health management. To prevent HEV infection in Cambodia, proper water hygiene
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is regarded as the first necessary measure. Multivariate analysis also showed that house workers
had a significantly higher rate of anti-HEV IgG positivity than farmers, office workers, stu-
dents, and craftsmen, which suggested possible problems with water hygiene for cooking or
washing the cloth, or handling with raw stuff [44].
The HEV isolate fully sequenced in this study is most closely related to the strains isolated
from swine in Guangxi and Guangdong, both in southern China. The cause of HEV infection
for the participants with detected HEV RNA (including the CVS-Sie10 isolate) is unknown;
however, HEV is a zoonotic pathogen that infects pigs, wild boars, and other animals, and
causal relationship between consumption of contaminated meat and hepatitis E onset has been
confirmed [29]. In Japan, the majority of foodborne infections are presumed to be related to
meat consumption [32], which can be also true in Cambodia; therefore, it is possible that the
consumption of undercooked meat or drinking water contaminated by animal waste may be
the cause of HEV infection for the participants in this study.
In Japan, HEV infection by blood transfusion has been reported in Hokkaido [45, 46],
which is regarded as a region with increasing danger of HEV infection; therefore, it is the only
place in the world where donor blood is screened for HEV RNA. In recent years, HEV infection
through blood transfusion has been regarded as a growing problem also in the West, and the
pros and cons of HEV blood screening have been considered. In this study, we identified HEV
genotype 4 characterized with high post-infection aggravation rate, and also found that new
HEV infections occur very frequently in Cambodia, raising concerns about HEV infection
through blood transfusion and suggesting that it may be necessary to enhance the safety of
blood supply.
The present study is the first to detect HEV genotype 4 in human blood in Cambodia and to
report sequencing of genotype 4 full-length genome. Our survey revealed high HEV prevalence
among Cambodian general population, including frequent cases of early HEV infection, sug-
gesting that measures to prevent HEV infection, such as improving water and food safety and
spreading health and hygiene education in school, are urgently required.
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